
    
      This single site study, is enrolling Parkinson disease (PD) patients and their family members
      and is limited to participants of Ashkenazi (Eastern European) Jewish descent with GBA and
      LRRK2 mutations, or with 3 or more family members with PD. Follow-up will be for three years.
      Participants must be in the New York City area yearly and willing to come to Mount Sinai
      Downtown for yearly 2 hour study visits which include obtaining personal medical and family
      history information, blood, urine and spinal fluid samples, neurological exam and
      neuropsychiatric testing. De-identified data and samples will be securely stored at a central
      NIH-run repository for access by other researchers. Spinal fluid collection is encouraged but
      optional.
    
  